Short Interest in GB Sciences, Inc. (OTCMKTS:GBLX) Declines By 10.0%

GB Sciences, Inc. (OTCMKTS:GBLX) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 900 shares, a decline of 10.0% from the March 31st total of 1,000 shares. Based on an average trading volume of 218,100 shares, the days-to-cover ratio is currently 0.0 days.

GB Sciences Stock Performance

Shares of OTCMKTS:GBLX remained flat at $0.01 during trading on Tuesday. The stock had a trading volume of 417,526 shares, compared to its average volume of 124,517. GB Sciences has a 12-month low of $0.01 and a 12-month high of $0.02. The company has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01.

GB Sciences Company Profile

GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.